Patents Assigned to Abattis Bioceuticals Corp
  • Patent number: 8916211
    Abstract: A method and composition for preventing and treating avian influenza utilizes an effective quantity of polyphenolic(s) and its derivatives in combination with a carrier. The anti-avian influenza ingredient having a composition selected from the group consisting of theaflavin, theaflavin-3,3?-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3?-gallate, thearubigin, gallic acid, tannic acid, (?)-epigallocatechin gallate (EGCG), (?)epigallocatechin (EGC), (+)-epicatechin (EC), (?)-gallocatechin gallate (GCG), and catechin.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: December 23, 2014
    Assignee: Abattis Bioceuticals Corp.
    Inventors: Charles Hensley, Sung Pyo
  • Publication number: 20130253047
    Abstract: A method and composition for preventing and treating avian influenza utilizes an effective quantity of polyphenolic(s) and its derivatives in combination with a carrier. The anti-avian influenza ingredient having a composition selected from the group consisting of theaflavin, theaflavin-3,3?-digallate, theaflavin-3-monogallate, theaflavin-3 gallate, theaflavin-3?-gallate, thearubigin, gallic acid, tannic acid, (?)-epigallocatechin gallate (EGCG), (?)epigallocatechin (EGC), (+)-epicatechin (EC), (?)-gallocatechin gallate (GCG), and catechin.
    Type: Application
    Filed: May 22, 2013
    Publication date: September 26, 2013
    Applicant: Abattis Bioceuticals Corp
    Inventors: Charles Hensley, Sung Pyo